OR4A42P

Across TCGA pan-cancer cohorts, OR4A42P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated OR4A42P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher OR4A42P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR4A42P expression acts as an unfavorable survival marker.

HNSC, UCEC, and BRCA are the cancer types where OR4A42P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	II,III,IV	0.359	0.690	.002	126	view →
UCEC	DFS	Tertile	All	0.596	0.899	.002	96	view →
BRCA	OS	Tertile	II,III,IV	0.430	0.913	.005	36	view →
LGG	OS	Tertile	All	0.475	0.897	<.001	36	view →
BLCA	DFS	Tertile	II,III,IV	0.159	0.625	.017	18	view →
STAD	DFS	Tertile	All	0.305	0.566	.009	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

OR4A42P–HNSC (DFS)

Open the HNSC breakdown →